Symbols

AHCO

AdaptHealth·NASDAQ

--(--)

AHCO fundamentals

AHCO Q4 2025 Earnings

AdaptHealth (AHCO) released its earnings on Feb 24, 2026: revenue was 846.29M (YoY -1.21%), beat estimates; EPS was 0.2631 (YoY -38.34%), missed estimates.

Revenue / YoY

846.29M

-1.21%

EPS / YoY

0.2631

-38.34%

Report date

Feb 24, 2026

AHCO Earnings Call Summary for Q4,2025

Revenue Growth: Full-year organic growth of 1.7%, driven by sleep (4% patient census) and respiratory (record oxygen/vent census). Q4 revenue exceeded guidance.
Profitability: Adjusted EBITDA of $616.7 million (19.0% margin), excluding one-time costs. 2026 EBITDA margin expected to improve by 1%.
Capitated Contract Impact: 5%-6% revenue growth contribution in 2026, with smoother-than-expected Q4 2025 go-live.
Balance Sheet Strength: $219.4 million free cash flow, $250 million debt reduction, upgraded credit ratings.
Operational Excellence: AI pilots doubled digital engagement, centralized order intake reduced setup times by 59% in sleep.

Earnings

EPS

Revenue

Revenue & Expenses

AHCO has released its 2025 Q4 earnings report, with revenue of 846.29M, reflecting a YoY change of -1.21%, and net profit of -101.54M, showing a YoY change of -297.53%. The Sankey diagram below clearly presents AHCO's revenue sources and cost distribution.

Key Indicators

AdaptHealth (AHCO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

AdaptHealth (AHCO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

AdaptHealth (AHCO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

AdaptHealth (AHCO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown